ProSomnus, Inc.
OSAPQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.18M
Close$
Share Statistics
| Market cap | $8.18 Million |
|---|---|
| Enterprise Value | $24.07 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.49 |
| Beta | 0.17 |
| Outstanding Shares | 17,393,524 |
Return
| Return on Equity | 60.88% |
|---|---|
| Return on Assets | -113.05% |
| Return on Invested Capital | -222.07% |
Valuation & Multiples
| P/E Ratio | -0.32 |
|---|---|
| PEG | 0.02 |
| Price to Sales | 0.01 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 0.77 |
| Enterprise Value to EBIT | -1.7 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.85 |
| Debt to Equity | -0.42 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ProSomnus, Inc.
136 employees
CEO: Leonard Liptak ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to slee...